Join us in Chicago on April 12-13, 2016 for MedCity INVEST, the premier national healthcare investing conference based in the Midwest.
Register by 4/4 for the extended early bird rate.
MedCity INVEST unites active investors and corporate development execs with healthcare’s most promising startups from the biotech, medical device, digital health, diagnostics, pharma, and regenerative medicine sectors.
More than 300 innovative thought leaders, prominent industry players, venture capitalists and angel investors will discuss the latest trends in investing, the business of medicine, the best opportunities and more. See complete agenda.
Hurry – Regiser Now! We’ve extended the early bird rate—ends 4/4.
MedCity INVEST Sessions Include:
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Liz Rockett
Principal
Kaiser Permanente Ventures
What’s Investable in Digital Health?
Noah Lewis, Managing Director, GE Ventures (@GE_Ventures)
Mohamad Makhzoumi, Partner, New Enterprise Associates (@NEAVC )
Liz Rockett, Principal , Kaiser Permanente Ventures
Tom Sudow, Director Business Development, Cleveland Clinic Innovations
What are the opportunities for investors and entrepreneurs in the digital health space? Which parts of digital health have advanced their business models, and where are the openings in hot spaces like data and telemedicine?
Robert Mittendorff, M.D.
Partner
Norwest Venture Partners
How Far Away Is a Real Direct-to-Consumer Business Model?
Skip Fleshman, Managing Partner, Asset Management Ventures
Robert Mittendorff, M.D., Partner, Norwest Venture Partners
Dave Schulte, Managing Director, McKesson Ventures (@davemschulte)
Garrett Vygantas, M.D., Partner, Jump Capital (@Vyggers)
Companies and consumers alike advocate for direct-to-consumer healthcare. But more often than not, the business models don’t work or the products don’t pass the consumer smell test. What still isn’t working? What barriers— regulatory, industry culture and approach—continue to stand in the way? And who is getting it right?
Investment Professional
Providence Ventures
Best Practices With Corporate Venture Capital in Digital Health
Anna Haghgooie, Managing Director, Sandbox Industries (@SandboxInd)
Lisa Maki, Co-founder and CEO, PokitDok (@LisaMMaki)
Cyril Philip, Investment Professional, Providence Ventures
Gavin Teo, Principal, Comcast Ventures (@gavinteo)
There are an increasing number of digital health corporate venture capital funds. Listen to fund managers who are getting it right and from startups who engage corporate VC discuss best practices, what to watch for and how to best engage with corporate venture capital.
Register by 4/4 for the extended early bird rate.
Plus these sessions and more:
- After the IPO: What Have We Learned?
- New Commercialization in Biopharma: Adapting The Accelerator & Building New Partnerships
- CEOs on IPOs: Managing A Company From Private to Public in Today’s Market
MedCity INVEST is the best place to discover the trends and up-and-coming startups in the life sciences and healthcare. Make plans to attend today.
********
MedCity INVEST will be held April 12-13 in Chicago at the Four Seasons. MedCity INVEST is considered to be the premier national healthcare investing event based in the Midwest. For more information, visit the MedCity INVEST web site and register here.
The event is a unique partnership between MedCityNews.com, the country’s most important site for insight on the business of healthcare innovation, and the Mid-America Healthcare Investors Network, an alliance of investors from throughout the Midwest and beyond.
